We are proud to share that Lorenzo Guglielmetti has been named to the 2025 TIME100 Health list, honoring the most influential people driving change and innovation in health and medicine globally.
This recognition highlights the significance of the endTB clinical trial led by Lorenzo and others, but also underscores the growing momentum and transformative progress being made in the fight against TB.
We are honored to see this work recognized on such a prominent and global stage, at a time when scientific research, innovation and equity in health are more critical than ever.
For more information on the 2025 TIME100 Health list, please visit: https://time.com/collections/time100-health-2025/
